×
搜尋
About
About SHINER
History
Research
News
Certificate/License
Events
Product
Drug Products
Medical Devices
Oral Supplements
Cooperate
Consulation Services
In-Licensing/Out-Licensing
Drug Products
Medical Devices
Oral Supplements
Contact
CH /
EN
About shinerpharm
Company Profile
Corporate Vision
Research and Development
Business Cooperation
Latest News
Latest News
Product Introduction
Drug Products
Medical Devices
Oral Supplements
Recruitment
104 Job Bank
Contact Us
Contact Us
最新消息
HOME
最新消息
Certificate / License
內文
Certificate / License
Events
Shiner's pms-Methylphenidate ER 18mg Tablets receives TFDA approval for the treatment of ADHD. (ANDA, API: methylphenidate hydrochloride)
2016-03-07
／
Certificate / License
Back to top
